The IMID Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Latest episodes
Jul 3, 2025 • 41min
Difficult-to-treat disease in Rheumatology Podcast Professors Iain McInnes and Peter Nash
Join Professor Iain McInnes from the University of Glasgow, and Professor Peter Nash from the Griffith University in Brisbane, as they discuss the concept of difficult-to-treat disease in rheumatology.
Jul 2, 2025 • 1h 5min
EULAR 2025 Review Podcast
Join Professors Xenofon Baraliakos, Laura Coates, and Johannes Bijlsma as they review their highlights of the recent EULAR 2025 congress, and watch them discuss the key abstracts and information.
Jun 26, 2025 • 15min
Discussing RA: Impact of TOF on BMI, UPA monotherapy in MTX-IRs, and JAKis vs TNFis treatment
Join Professor Iain McInnes and Professor Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA.
In this episode, they discuss three papers: the impact of TOF treatment on weight and BMI in RA patients, to that of alternate treatment options for RA patients with prior MTX-inadequate response, and the treatment of JAKis versus TNFis in RA.
Jun 14, 2025 • 3min
EULAR 2025 Highlights: Day 4
Join Professor Xenofon Baraliakos as he summarises his top abstracts, posters, and presentations from Day 4 of EULAR 2025 (Saturday, June 14).
Jun 13, 2025 • 3min
EULAR 2025 Highlights: Day 3
Join Professor Xenofon Baraliakos as he summarises his top abstracts, posters, and presentations from Day 3 of EULAR 2025 (Friday, June 13).
Jun 12, 2025 • 23min
Discussing PsA: Real-world data on biologic switching and the development of EMMs
Join Professors Philip Mease and Laura Coates and as they discuss the top publications in the world of PsA. This month, the conversation covered a discussion on biologic switching for the treatment of PsA using real-world data as well as the development of extramusculoskeletal manifestations in PsA and axSpA patients treated with upadacitinib.
Jun 12, 2025 • 5min
EULAR 2025 Highlights: Day 2
Join Professor Xenofon Baraliakos as he summarises his top abstracts, posters, and presentations from Day 2 of EULAR 2025 (Thursday, June 12).
Jun 11, 2025 • 4min
EULAR 2025 Highlights: Day 1
Join Professor Xenofon Baraliakos as he summarises his top abstracts, posters, and presentations from Day 1 of EULAR 2025 (Wednesday, June 11).
Jun 9, 2025 • 25min
EULAR 2025 Preview Podcast
Join Professors Xenofon Baraliakos, Laura Coates, and Johannes Bijlsma as they guide you through what they are most looking forward to in RA, PsA, and axSpA at EULAR 2025, so that you can better plan your time at what will be a busy and exciting congress.
Jun 5, 2025 • 10min
Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA.
In this episode, he discusses two papers: risk of MACE in patients with RA treated with JAKis compared to bDMARDs from the “JAK-pot” study, and the efficacy and safety of zimlovisertib, ritlecitinib and tofacitinib, alone and in combination, in patients with RA and an inadequate response to MTX.
